152 related articles for article (PubMed ID: 21757966)
21. Overexpression of hypoxia-inducible factor 1α is associated with neutrophilic inflammation in chronic rhinosinusitis with nasal polyps.
Yu Z; Wang Y; Hu X; Xu H; Han M; Zhang J; Wen W; Shu H; Li H
Auris Nasus Larynx; 2020 Jun; 47(3):401-409. PubMed ID: 31635898
[TBL] [Abstract][Full Text] [Related]
22. Effect of long-term, low-dose clarithromycin on T helper 2 cytokines, eosinophilic cationic protein and the 'regulated on activation, normal T cell expressed and secreted' chemokine in the nasal secretions of patients with nasal polyposis.
Perić A; Vojvodić D; Matković-Jožin S
J Laryngol Otol; 2012 May; 126(5):495-502. PubMed ID: 22559798
[TBL] [Abstract][Full Text] [Related]
23. Long-term outcomes from the English national comparative audit of surgery for nasal polyposis and chronic rhinosinusitis.
Hopkins C; Slack R; Lund V; Brown P; Copley L; Browne J
Laryngoscope; 2009 Dec; 119(12):2459-65. PubMed ID: 19780032
[TBL] [Abstract][Full Text] [Related]
24. The effect of topical amphotericin B on inflammatory markers in patients with chronic rhinosinusitis: a multicenter randomized controlled study.
Ebbens FA; Georgalas C; Luiten S; van Drunen CM; Badia L; Scadding GK; Hellings PW; Jorissen M; Mullol J; Cardesin A; Bachert C; van Zele TP; Lund VJ; Fokkens WJ
Laryngoscope; 2009 Feb; 119(2):401-8. PubMed ID: 19160404
[TBL] [Abstract][Full Text] [Related]
25. Oral steroids and doxycycline: two different approaches to treat nasal polyps.
Van Zele T; Gevaert P; Holtappels G; Beule A; Wormald PJ; Mayr S; Hens G; Hellings P; Ebbens FA; Fokkens W; Van Cauwenberge P; Bachert C
J Allergy Clin Immunol; 2010 May; 125(5):1069-1076.e4. PubMed ID: 20451040
[TBL] [Abstract][Full Text] [Related]
26. Myeloperoxidase in nasal secretion as a cell-activation marker in acute sinusitis.
Haxel BR; Woywode C; Mewes T; Mann WJ
Am J Rhinol; 2004; 18(2):93-8. PubMed ID: 15152874
[TBL] [Abstract][Full Text] [Related]
27. A double-blind, randomized, placebo-controlled trial of macrolide in the treatment of chronic rhinosinusitis.
Wallwork B; Coman W; Mackay-Sim A; Greiff L; Cervin A
Laryngoscope; 2006 Feb; 116(2):189-93. PubMed ID: 16467702
[TBL] [Abstract][Full Text] [Related]
28. [Polypous rhinosinusitis in the context of the asthma triad].
Tsyvkina AA; Tsarev SV
Vestn Otorinolaringol; 2011; (1):77-80. PubMed ID: 21378746
[TBL] [Abstract][Full Text] [Related]
29. Safety and efficacy of once-daily nasal irrigation for the treatment of pediatric chronic rhinosinusitis.
Wei JL; Sykes KJ; Johnson P; He J; Mayo MS
Laryngoscope; 2011 Sep; 121(9):1989-2000. PubMed ID: 22024856
[TBL] [Abstract][Full Text] [Related]
30. The efficacy of clarithromycin in patients with severe nasal polyposis.
Dabirmoghaddam P; Mehdizadeh Seraj J; Bastaninejad S; Meighani A; Mokhtari Z
Acta Med Iran; 2013 Jul; 51(6):359-64. PubMed ID: 23852839
[TBL] [Abstract][Full Text] [Related]
31. Reversible nasal airway obstruction: does change in nasal peak inspiratory flow following decongestion predict response to topical steroids in chronic rhinosinusitis patients?
Koo Ng NK; Young D; McGarry GW
J Laryngol Otol; 2012 Dec; 126(12):1238-40. PubMed ID: 23057871
[TBL] [Abstract][Full Text] [Related]
32. Efficacy and tolerability of bromelain in patients with chronic rhinosinusitis--a pilot study.
Büttner L; Achilles N; Böhm M; Shah-Hosseini K; Mösges R
B-ENT; 2013; 9(3):217-25. PubMed ID: 24273953
[TBL] [Abstract][Full Text] [Related]
33. Topical antifungal treatment of chronic rhinosinusitis with nasal polyps: a randomized, double-blind clinical trial.
Weschta M; Rimek D; Formanek M; Polzehl D; Podbielski A; Riechelmann H
J Allergy Clin Immunol; 2004 Jun; 113(6):1122-8. PubMed ID: 15208594
[TBL] [Abstract][Full Text] [Related]
34. The value of a feasibility study into long-term macrolide therapy in chronic rhinosinusitis.
Bewick J; Ahmed S; Carrie S; Hopkins C; Sama A; Sunkaraneni V; Woods J; Morris S; Erskine S; Philpott CM
Clin Otolaryngol; 2017 Feb; 42(1):131-138. PubMed ID: 27223120
[TBL] [Abstract][Full Text] [Related]
35. Molecular and cellular staging for the severity of chronic rhinosinusitis.
Kountakis SE; Arango P; Bradley D; Wade ZK; Borish L
Laryngoscope; 2004 Nov; 114(11):1895-905. PubMed ID: 15510011
[TBL] [Abstract][Full Text] [Related]
36. Effect of nasal antifungal therapy on nasal cell activation markers in chronic rhinosinusitis.
Weschta M; Rimek D; Formanek M; Podbielski A; Riechelmann H
Arch Otolaryngol Head Neck Surg; 2006 Jul; 132(7):743-7. PubMed ID: 16847182
[TBL] [Abstract][Full Text] [Related]
37. Multimodality topical therapy for refractory chronic rhinosinusitis: our experience in thirteen patients with and twelve patients without nasal polyps.
Shikani AH; Kourelis K; Alqudah MA; Shikani HJ; Cope E; Kirk N; Bergstedt D; Basaraba RJ; Leid JG
Clin Otolaryngol; 2013 Jun; 38(3):254-8. PubMed ID: 23398898
[No Abstract] [Full Text] [Related]
38. Clarithromycin and prednisolone inhibit cytokine production in chronic rhinosinusitis.
Wallwork B; Coman W; Feron F; Mackay-Sim A; Cervin A
Laryngoscope; 2002 Oct; 112(10):1827-30. PubMed ID: 12368623
[TBL] [Abstract][Full Text] [Related]
39. Clarithromycin and dexamethasone show similar anti-inflammatory effects on distinct phenotypic chronic rhinosinusitis: an explant model study.
Zeng M; Li ZY; Ma J; Cao PP; Wang H; Cui YH; Liu Z
BMC Immunol; 2015 Jun; 16():37. PubMed ID: 26047816
[TBL] [Abstract][Full Text] [Related]
40. Effects of systemic steroid treatment in chronic polypoid rhinosinusitis evaluated with magnetic resonance imaging.
Damm M; Jungehülsing M; Eckel HE; Schmidt M; Theissen P
Otolaryngol Head Neck Surg; 1999 Apr; 120(4):517-23. PubMed ID: 10187944
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
